The Cross-Border Biotech Blog

Biotechnology, Health and Business in Canada, the United States and Worldwide

Biotech Bailout: Israel Edition

Israel’s Ministry of Finance announced a two-part stimulus for high-tech and biotech companies. 

  • The first part is an additional infusion of NIS 150 million (US$37 million) for the Office of the Chief Scientist, which runs a variety of R&D and commercialization programs. 
  • The second part is NIS 250 million (US$61 million) to set up a new fund specializing in biotechnology investments. The fund will be leveraged by the private sector and will reach a total of between NIS 750 million and 1 billion, and will be managed by an experienced management body with expertise in the biotech R&D sector.

Bookmark and Share

About these ads

2 responses to “Biotech Bailout: Israel Edition

  1. Pingback: Trends in 2009: Shifting IP Constituencies « The Cross-Border Biotech Blog

  2. Pingback: There’s No Bailout Like a Good Exit « The Cross-Border Biotech Blog

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

Follow

Get every new post delivered to your Inbox.

Join 129 other followers